Leerink Partners Maintains Outperform on Ardent Health, Lowers Price Target to $15
Leerink Partners analyst Whit Mayo maintains Ardent Health (NYSE:ARDT) with a Outperform and lowers the price target from $16 to $15.
Login to comment